Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias?
- PMID: 36610068
- PMCID: PMC10169440
- DOI: 10.1093/eurheartj/ehac638
Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias?
Conflict of interest statement
Conflict of interest: None declared.
Figures
Comment in
-
Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply.Eur Heart J. 2023 Feb 14;44(7):626. doi: 10.1093/eurheartj/ehac742. Eur Heart J. 2023. PMID: 36610071 Free PMC article. No abstract available.
Comment on
-
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.Eur Heart J. 2022 Oct 14;43(39):3960-3967. doi: 10.1093/eurheartj/ehac377. Eur Heart J. 2022. PMID: 35869873 Free PMC article.
References
-
- Mitchell RE, Hartley A, Walker VM, Gkatzionis A, Yarmolinsky J, Bell JA, et al. . Strategies to investigate and mitigate collider bias in genetic and Mendelian randomization studies of disease progression. medRxiv, 10.1101/2022.04.22.22274166, 22 April 2022, preprint: not peer reviewed. - DOI - PMC - PubMed
